A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder

Metabolic Brain Disease

Volumn 21, Issue 2-3, 2006, Pages 241-252

  Warwick, J M ^a,c   Carey, P ^a   Van Der Linden, G ^a   Prinsloo, C ^a   Niehaus, D ^a   Seedat, S ^a   Dupont, P ^b   Stein, D J ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cingulate; Citalopram; Insula; Moclobemide; Social phobia; SPECT

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; MOCLOBEMIDE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGORAPHOBIA; ARTICLE; BRAIN; BRAIN CIRCULATION; COMPARATIVE STUDY; DEPTH PERCEPTION; DRUG EFFECT; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGORAPHOBIA; ANTIDEPRESSIVE AGENTS; BRAIN; CEREBROVASCULAR CIRCULATION; CITALOPRAM; FEMALE; HUMANS; MALE; MOCLOBEMIDE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SPACE PERCEPTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248667731     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-006-9009-2     Document Type: Article

References (39)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2. Ballenger JC (1998) Focus on social anxiety disorder. J Clin Psychiatry 59(suppl. 17):3
3. Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, Schneider F, Weiss U, Flor H (1998) fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9:1223-1226 (Pubitemid 28266653)
4. Carey PD, Warwick J, Niehaus DJ, Van der Linden G, Van Heerden BB, Harvey BH, Seedat S, Stein DJ (2004) Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry 4:30
5. Chang LT (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 25:638-643
6. Coplan JD, Lydiard RB (1998) Brain circuits in panic disorder. Biol Psychiatry 44:1264-1276 (Pubitemid 29015864)
7. Deakin JWF et al (1991) J Psychopharmacol 5:305-315
8. de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J (2005) Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30:996-1005 (Pubitemid 40570914)
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Edition. Biometrics Research Department, New York State Research Institute, NY
10. Friston KJ, Frith CD, Liddle PF, Frackowiak RS (1991) Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 11:690-699
11. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioural therapy. Arch Gen Psychiatry 59:425-433. (Pubitemid 34477677)
12. Geday J, Hermansen F, Rosenberg R, Smith DF (2005) Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans. Synapse 55:224-229 (Pubitemid 40256304)
13. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129-141 (Pubitemid 26146666)
14. Kent JM, Coplan JD, Lombardo I, Hwang D, Huang Y, Mawlawi O, Van Heertum RL, Slifstein M, Abi-Dargham A, Gorman JM, Laruelle M (2002) Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652. Psychopharmacology 164:341-348 (Pubitemid 35435709)
15. Kessler RM (2003) Imaging methods for evaluating brain function in man. Neurobiol Aging 24:S21-35
16. LeDoux J (1998) Fear and the brain: where have we been and where are we going? Biol Psychiatry 44:1229-1238
17. Liebowitz MR (1987) Social Phobia. Mod Probl Pharmacopsychiat 22:141-173
18. Liebowitz MR, Schneier FR, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R, Klein DF (1992) Phenelzine versus atenolol in social phobia: a placebo-controlled trial. Arch Gen Psychiatry 49:290-300
19. Lorderbaum JP, Kose S, Johnson MR, Arana GW, Sullivan LK, Hamner MB, Ballenger JC, Lydiard RB, Brodrick PS, Bohning DE, George MS (2004) Neural correlates of speech anticipatory anxiety in generalised social phobia. Neuroreport 15:2701-2705 (Pubitemid 40070977)
20. Madsen PL, Vorstrup S, Schmidt JF, Paulson OB (1990) Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers. Eur J Clin Pharmacol. 39:295-297 (Pubitemid 20336152)
21. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC (1996) Agoraphobia, simple phobia and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159-168 (Pubitemid 26049391)
22. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382-389 (Pubitemid 9136500)
23. New AS, Buchsbaum MS, Hazlett EA, Goodman M, Koenigsberg HW, Lo J, Iskander L, Newmark R, Brand J, O'Flynn K, Siever LJ (2004) Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) 176:451-458 (Pubitemid 40017172)
24. Nutt DJ, Bell CJ, Malizia AL (1998) Brain mechanisms of social anxiety disorder. J Clin Psychiatry 59(suppl. 17):4-9 (Pubitemid 28487502)
25. Roy-Byrne P, Fleishaker J, Arnett C, Dubach M, Stewart J, Radant A, Veith R, Graham M (1993) Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines. Neuropsychopharmacology 8:161-169 (Pubitemid 23051864)
26. Schneider F, Weiss U, Kessler C, Muller-Gartner HW, Posse S, Salloum JB, Grodd W, Himmelmann F, Gaebel W, Birbaumer N (1999) Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 45:863-871 (Pubitemid 29185477)
27. Sheehan D (1983) The anxiety disease, Scribners, New York
28. Smith GS, Kramer E, Hermann CR, Goldberg S, Ma Y, Dhawan V, Barnes A, Chaley T, Belakhleff A, Laghrissi-Thode F, Greenwald B, Eidelberg D, Pollock BG (2002) Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry 10:715-723 (Pubitemid 35315707)
29. Stein DJ, Westenberg HGM, Liebowitz MR (2002) Social anxiety disorder and generalised anxiety disorder: serotoninergic and dopaminergic neurocircuitry. J Clin Psychiatry 63(suppl 6):12-19 (Pubitemid 34438945)
30. Stein MB, Leslie WD (1996) A brain single photon-emission computed tomography (SPECT) study of generalized social phobia. Biol Psychiatry 39:825-828 (Pubitemid 26156749)
31. Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M (2001) Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry 158:1220-1226 (Pubitemid 32717694)
32. Tillfors M, Furmark T, Marteinsdottir I, Fredrikson M (2002) Cerebral blood flow during anticipation of public speaking in social phobia: a PET study. Biol Psychiatry 52:1113-1119 (Pubitemid 35379968)
33. Van Ameringen M Mancini C, Szechtman H, Nahmias C, Oakman JM, Hall GBC, Pipe B, Farvolden P (2004) A PET provocation study of generalised social phobia. Neuroimaging 132:13-18 (Pubitemid 39531321)
34. Van der Linden GJ, Stein DJ, Van Balkom AJ (2000) The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomised controlled trials. Int Clin Psychopharmacol 15(suppl. 2):S15-S23
35. Van der Linden G, Van Heerden B, Warwick J, Wessels C, Van Kradenburg J, Zungu-Dirwayi N, Stein DJ (2000) Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuro-psychopharmacol and Biol Psychiat 24:419-438 (Pubitemid 30261826)
36. Varnäs K, Halldin C, Hall H (2004) Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22:246-260 (Pubitemid 38891003)
37. Veit R, Flor H, Erb M, Hermann C, Lotze M, Grodd W, Birbaumer N (2002) Brain circuits involved in emotional learning in antisocial behaviour and social phobia in humans. Neuroscience Letters 328:233-236 (Pubitemid 34876654)
38. Wittchen HU, Beloch E (1996) The impact of social phobia on quality of life. Int Clin Psychopharmacol 11(suppl. 3):15-23
39. Weiller E, Bisserbe J-C, Boyer P, Lepine JP, Lecrubier Y (1996) Social phobia in general health care: An unrecognised undertreated disabling disorder. Br J Psychiatry 168:169-174